Allarity Therapeutics Inc. is on the Cruelty-Free Investing usage of animals list because they undertake pre-clinical studies on animals to examine the safety profile of their medications.
The company stated in the following press release that they use animals for product testing.
“The purpose of the study was to investigate the capacity of dovitinib alone, and in combination with a specific checkpoint inhibition strategy (anti-PD-1), for slowing the progression of experimental pulmonary metastases in animal models of osteosarcoma.” Read the following article
Allarity Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. The Company focuses on developing novel and oncology therapeutics for the treatment of patients with cancer diseases. Allarity Therapeutics serves customers in the United States and Denmark.
Company Website: https://allarity.com